Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials

Fig. 3

Mixed comparison results of anti-diabetic agents for MACE and all-cause mortality, both for individual (above table) and for categorized agents (below table). Agents are reported in order of MACE ranking. Treatment at the top left corner ranks first, while the one at the bottom right corner ranks last. OR lower than 1 favor the column-defining treatment. Anti-diabetic agents in one class are painted with the same color. Significant results are in bold

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840